CNS PHARMAC. INC. DL-,001 Aktie

For the quarter ended May 31, 2026, CNS reported earnings per share of 60.39 JPY (prior year 43.96 JPY) with revenue rising 13.11% to 2.06 billion JPY. Full-year EPS was 203.31 JPY versus 147.06 JPY in the prior year. Annual revenue increased 10.98% to 7.77 billion JPY. » More on finanzen.net